Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 28.09.2019

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
28.09.19Phase 3 PRIMA trial of Zejula (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless of biomarker status, when given as monotherapy in women with first-line platinum responsive advanced ovarian cancer732The PRIMA study, presented in a Presidential Symposium at the 2019 European Society for Medical Oncology congress and simultaneously published in The New England Journal of Medicine, demonstrates...
► Artikel lesen
28.09.19SDRPY Greets UK Parliamentary Delegation in Riyadh512RIYADH, Saudi Arabia, Sept. 28, 2019 /PRNewswire/ -- On Wednesday, a British parliamentary delegation headed by MP John Woodcock was welcomed at the headquarters of the Saudi Development...
► Artikel lesen
28.09.19BERG Presents First-In-Kind Data Using Its Bayesian AI-Driven Interrogative Biology Technology To Map Underlying Biology Of Patient Responses In Advanced Solid Tumor Trial Of BPM31510576Early phase study of BPM31510 demonstrates BERG's Interrogative Biology platform can identify the molecular basis of efficacy and adverse events, offering critical insights for drug late-stage...
► Artikel lesen
28.09.19Warburg Pincus Announces Sale of inexio515BERLIN, Sept. 28, 2019 /PRNewswire/ -- Warburg Pincus, a leading global private equity firm focused on growth investing, today announced the sale of inexio (www.inexio.net), a leading provider...
► Artikel lesen